mTOR Inhibitor Therapy for Tuberous Sclerosis Complex: Longitudinal Study of Muscle Mass Determined by Abdominal Cross-sectional Imaging with CT and MRI.

Caroline RaabLeah A Gilligan Andrew T TroutDarcy A KruegerDavid N FranzBin Zhang Alexander J Towbin

Published in: Radiology. Imaging cancer (2020)

Duration of mTOR inhibition in TSC was not significantly associated with a decrease in psoas muscle area, suggesting that chronic mTOR inhibition is not associated with sarcopenia.Keywords: CT, MR-Imaging, Pediatrics© RSNA, 2020.

Keyphrases

contrast enhanced
magnetic resonance imaging
cell proliferation
computed tomography
cross sectional
image quality
dual energy
magnetic resonance
skeletal muscle
diffusion weighted imaging
high resolution
positron emission tomography
drug induced
photodynamic therapy
fluorescence imaging